NCAB Task Force Urges New Study Section For Clinical Cancer Research, Sees “Crisis”
In Brief: Henderson Names to HHA Post; Nurses Support Cigarette Tax Increase; FDA Staff Changes
Komen Foundation Shifts Emphasis To Underserved
Clinton Budget For NIH “Disappointing,” AACR executive Director Says
ACS Expresses Concern About “Fletcher Report” On Mammography
FDA Ceases Exclusion Of Women From Early Drug Studies
ACS Encourages Grant Applications In All Aspects Of Pain Control
Trending Stories
- Mt. Sinai forms committee to probe Epstein links to breast center founder Eva Dubin, other faculty members
- Break Through Cancer’s Tyler Jacks: “We’ve created a new operating model for collaborative cancer research.”
- Vinay Prasad, oncology’s gadfly-turned-CBER-director, will leave FDA (again)
- One result, two reactions: GRAIL’s Hall and NCI’s Castle react to negative NHS-Galleri trial outcome
- As more people are surviving cancer, we must continue funding bold science
- GRAIL presses on with Galleri test despite missed primary endpoint in pivotal study
Where GRAIL sees signals of benefit in the subgroups, screening experts see signs of overdiagnosis









